We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
-5.2%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$2.67B
AUM Growth
+$265M
Cap. Flow
+$453M
Cap. Flow %
16.99%
Top 10 Hldgs %
13.61%
Holding
878
New
229
Increased
191
Reduced
239
Closed
127

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$21.6M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$19.6M
3
HAS icon
Hasbro
HAS
+$12.8M
4
BKU icon
Bankunited
BKU
+$10.4M
5
DLX icon
Deluxe
DLX
+$10.4M

Sector Composition

Rank Sector Weight
1 Financials 17.28%
2 Healthcare 13.75%
3 Technology 11.2%
4 Industrials 9.84%
5 Consumer Discretionary 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.81T
$50.1M 1.88%
1,817,352
+44,488
+3% +$1.3M
IWM icon
2
iShares Russell 2000 ETF
IWM
$82.4B
$46.9M 1.76%
429,850
+164,898
+62% +$19.6M
MSFT icon
3
Microsoft
MSFT
$2.95T
$39M 1.46%
880,399
-1,488
-0.2% -$66.8K
JPM icon
4
JPMorgan Chase
JPM
$901B
$37.6M 1.41%
616,679
-324
-0.1% -$21.2K
XOM icon
5
ExxonMobil
XOM
$629B
$35.5M 1.33%
477,266
+32,415
+7% +$2.5M
AMGN icon
6
Amgen
AMGN
$198B
$33.9M 1.27%
245,190
-6,797
-3% -$1.07M
NOC icon
7
Northrop Grumman
NOC
$74.4B
$32.1M 1.2%
193,217
-1,312
-0.7% -$220K
BAC icon
8
Bank of America
BAC
$430B
$32M 1.2%
2,053,532
+42,857
+2% +$721K
GE icon
9
GE Aerospace
GE
$354B
$30.4M 1.14%
251,855
-1,726
-0.7% -$212K
LLY icon
10
Eli Lilly
LLY
$1.02T
$25.5M 0.96%
305,153
+106,775
+54% +$9.01M
GILD icon
11
Gilead Sciences
GILD
$165B
$25.5M 0.96%
260,028
+71,361
+38% +$7.93M
UNH icon
12
UnitedHealth
UNH
$396B
$24.8M 0.93%
213,944
+17,590
+9% +$2.11M
INTC icon
13
Intel
INTC
$530B
$24.6M 0.92%
817,850
-11,686
-1% -$338K
GS icon
14
Goldman Sachs
GS
$311B
$22.2M 0.83%
127,967
-4,205
-3% -$824K
KDP icon
15
Keurig Dr Pepper
KDP
$41.4B
$22.2M 0.83%
280,415
+2,568
+0.9% +$201K
ELV icon
16
Elevance Health
ELV
$82.9B
$21.6M 0.81%
154,529
-8,695
-5% -$1.31M
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$4.24T
$21.4M 0.8%
+671,860
New +$21.6M
T icon
18
AT&T
T
$155B
$21.3M 0.8%
865,136
+267,321
+45% +$6.82M
BR icon
19
Broadridge
BR
$17.4B
$21.1M 0.79%
382,033
-2,283
-0.6% -$123K
DIS icon
20
Walt Disney
DIS
$167B
$20.8M 0.78%
203,125
+70,467
+53% +$7.67M
CAH icon
21
Cardinal Health
CAH
$52.9B
$20.3M 0.76%
264,883
-17,385
-6% -$1.45M
VLO icon
22
Valero Energy
VLO
$93B
$20.3M 0.76%
336,951
+47,447
+16% +$3.01M
PNC icon
23
PNC Financial Services
PNC
$99.8B
$19.6M 0.73%
219,187
-2,074
-0.9% -$195K
WFC icon
24
Wells Fargo
WFC
$261B
$19.5M 0.73%
380,620
-2,669
-0.7% -$147K
IWF icon
25
iShares Russell 1000 Growth ETF
IWF
$125B
$19.4M 0.73%
833,580
-84,000
-9% -$2.07M

Similar funds

Boston Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Boston Advisors held 878 positions worth $2.67B, up 11% from $2.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boston Advisors deployed $453M of net new capital in Q3 2015, opening 229 new positions and adding to 191 existing holdings. Its largest new stake was Alphabet (Google) Class A: 671,860 shares worth $21.4M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $23.3M trimmed.

  • Boston Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 671,860 shares worth $21.4M.
  • Boston Advisors added most to iShares Russell 2000 ETF in Q3 2015, an estimated $19.6M increase.
  • Boston Advisors's biggest Q3 2015 reduction was Bristol-Myers Squibb, cutting an estimated $23.3M.
  • Boston Advisors fully exited Thomson Reuters in Q3 2015, selling an estimated $13.1M.
  • Boston Advisors's ten largest holdings make up 14% of its $2.67B portfolio in Q3 2015.
  • Boston Advisors opened 229 new positions and closed 127 in Q3 2015.
  • Boston Advisors's portfolio value rose 11% quarter-over-quarter to $2.67B.

Based on Boston Advisors's 13F filing for Q3 2015, filed 28 Oct 2015.